MTOR.md
... ...
@@ -1,10 +1,7 @@
1 1
# MTOR
2 2
3
-<<Warn("The variants reported in this gene failed QC")>>
4
-
5
-**[See below ](#representative-mutations) or [the study page ](papers/paneaWholeGenomeLandscape2019.md#tier-2) for more information**
6
-
7 3
## Overview
4
+
8 5
Although mutations in MTOR have been reported in DLBCL<sup>1</sup> and some BL, their role in lymphomagenesis has not been thoroughly studied.
9 6
10 7
## History
PABPC4L.md
... ...
@@ -16,7 +16,7 @@ timeline
16 16
17 17
|Entity|Tier|Description |
18 18
|:------:|:----:|--------------------------------------|
19
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established|
19
+|![BL](images/icons/BL_tier2.png) |2-F |Failed QC|
20 20
21 21
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
22 22
... ...
@@ -50,5 +50,16 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/P
50 50
<!-- ORIGIN: paneaWholeGenomeLandscape2019 -->
51 51
<!-- BL: paneaWholeGenomeLandscape2019 -->
52 52
53
+## Representative Mutations
54
+
55
+![](primary/Panea_PABPC4L_1.svg)
56
+**Rating**
57
+&starf; &star; &star; &star; &star;
58
+
59
+![](primary/Panea_PABPC4L_2.svg)
60
+**Rating**
61
+&starf; &star; &star; &star; &star;
62
+
63
+
53 64
## References
54 65
1. Panea R, Love C, Shingleton JR, Reddy A, Bailey J, Moormann A, Otieno J, Ong’echa J, Oduor C, Schroêder K, Masalu N, Chao N, Agajanian M, Major M, Fedoriw Y, Richards K, Rymkiewicz G, Miles R, Alobeid B, Bhagat G, Flowers C, Ondrejka S, Hsi E, Choi W, Au-Yeung R, Hartmann W, Lenz G, Meyerson H, Lin YY, Zhuang Y, Luftig M, Waldrop A, Dave T, Thakkar D, Sahay H, Li G, Palus B, Seshadri V, Kim S, Gascoyne R, Levy S, Mukhopadhyay M, Dunson D, Dave S. The whole genome landscape of Burkitt lymphoma subtypes. Blood. 2019;